{"version":"1.0","provider_name":"FARMAPOL Sp. z o.o.","provider_url":"https:\/\/farmapol.pl\/en\/","author_name":"ad_min_developer","author_url":"https:\/\/farmapol.pl\/en\/author\/ad_min_developer\/","title":"European Union Funds - FARMAPOL Sp. z o.o.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HILykq7YA2\"><a href=\"https:\/\/farmapol.pl\/en\/fundusze-unijne\/\">European Union Funds<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/farmapol.pl\/en\/fundusze-unijne\/embed\/#?secret=HILykq7YA2\" width=\"600\" height=\"338\" title=\"&#8220;European Union Funds&#8221; &#8212; FARMAPOL Sp. z o.o.\" data-secret=\"HILykq7YA2\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/farmapol.pl\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Project\u00a0\u201cResearch and development on new medicine Asmag B6 Forte\u201d No RPWP.01.02.00-30-0012\/19 implemented under the Regional Operational Programme of the Wielkopolska Region 2014-2020. Measure: 1.2. The strengthening of the innovative potential of the Wielkopolska Region enterprises. Beneficiary: ZAK\u0141AD CHEMICZNO \u2013 FARMACEUTYCZNY \u201cFARMAPOL\u201d SP\u00d3\u0141KA Z OGRANICZON\u0104 ODPOWIEDZIALNO\u015aCI\u0104 The aim of the project is to conduct research and development works in favour of the creation of Asmag B6 Forte medicine containing magnesium citrate and vitamin B6. As part of the project, development of laboratory infrastructure is planned for the purpose of R+D works. Total value of the project:\u00a0PLN 931 400,00 Contribution of the EU:\u00a0PLN 620\u00a0000,00 The project is being implemented in Pozna\u0144 (ul. \u015aw. Wojciech 29, 61-749 Pozna\u0144) \u00a0 \u00a0","thumbnail_url":"http:\/\/farmapol.pl\/wp-content\/uploads\/2020\/04\/flaga-1024x107.jpg"}